FITLIFE BRANDS, INC.

Nasdaq:FTLF

Medicinal Chemicals & Botanical Products·OMAHA, NE

Summary Financials

Revenue

$19.5M

+14.2% YoY

FY 2020

Adj. EBITDA

$7.6M

39.2% margin

FY 2024

Net Income

$5.3M

27.2% margin

FY 2024

EPS (Diluted)

$0.54

FY 2024

Stock Price

$14.66

-0.6%

2026-03-10

52W Range

$9.83 – $20.98

P/E Ratio

27.1x

Market Cap

$137.7M

Cash

$259,000

FY 2020

Total Debt

$18.0M

FY 2024

Net Debt

$17.8M

FY 2024

Enterprise Value

$155.4M

Debt / EBITDA

2.3x

FY 2020

EV / EBITDA

20.3x

Employees

—

Revenue

$19.5M

+14.2% YoY

FY 2020

Adj. EBITDA

$7.6M

39.2% margin

FY 2024

Net Income

$5.3M

27.2% margin

FY 2024

EPS (Diluted)

$0.54

FY 2024

Stock Price

$14.66

-0.6%

2026-03-10

52W Range

$9.83 – $20.98

P/E Ratio

27.1x

Market Cap

$137.7M

Cash

$259,000

FY 2020

Total Debt

$18.0M

FY 2024

Net Debt

$17.8M

FY 2024

Enterprise Value

$155.4M

Debt / EBITDA

2.3x

FY 2020

EV / EBITDA

20.3x

Employees

—